GlaxoSmithKline announcement that the co will stop paying doctors to promote products shows again another major obstacle for a small co like Insmed ( who as of now says they do not plan to partner( I assume this means Will &Co want a takeover if NTM is successful.
Often newer better drugs come to market that get stifled by big pharma muscle (money).
Arikace for CF in the United States is stalled for perhaps just that reason.
For those of you that don't realize it,big pharma influences the FDA by funding the FDA. (PDUFA)